STOCK TITAN

Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) announces an Investor Presentation to reveal a major milestone regarding their breakthrough Augmented Respiration Technology. The technology aims to rebalance patient oxygen levels without invasive ventilation systems. The Company President, Mr. Joe Hayon, will present the details on March 4, 2024.
Positive
  • None.
Negative
  • None.

RA'ANANA, Israel, Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, announced today that the Company President, Director and co-founder, Mr. Joe Hayon, will present an Investor Presentation and announce the Company's next major milestone. The conference call is to be held at 9:00am Eastern Time on Monday, March 4, 2024.

Inspira Technologies Logo

To attend the conference call, please enter: link

Inspira Technologies OXY B.H.N. Ltd.

Inspira™ Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels. This technology potentially allows patients to remain awake during treatment while reducing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity.

For more information, please visit our corporate website: https://inspira-technologies.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected release of the investor presentation and announcement of its next major milestone. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website, www.sec.gov

For more details:

Public Relations Manager
Adi Shmueli
Inspira Technologies
info@inspirao2.com
+972-9-9664485

MRK-ARS-089

Copyright © 2018-2024 Inspira Technologies OXY B.H.N. LTD., All rights reserved.

Cision View original content:https://www.prnewswire.com/news-releases/inspira-to-host-conference-call-to-discuss-investor-presentation-and-announce-next-major-milestone-302072474.html

SOURCE Inspira Technologies

FAQ

What is the ticker symbol for Inspira Technologies OXY B.H.N. Ltd.?

The ticker symbol for Inspira Technologies OXY B.H.N. Ltd. is IINN.

What is the major milestone announced by Inspira Technologies?

Inspira Technologies announced an Investor Presentation to reveal details about their breakthrough Augmented Respiration Technology.

Who will present the Investor Presentation for Inspira Technologies?

Mr. Joe Hayon, the Company President, Director, and co-founder, will present the Investor Presentation.

When will the conference call be held?

The conference call will be held at 9:00am Eastern Time on Monday, March 4, 2024.

What is the purpose of the Augmented Respiration Technology developed by Inspira Technologies?

The Augmented Respiration Technology aims to rebalance patient oxygen saturation levels without the need for invasive mechanical ventilation systems.

Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares

NASDAQ:IINN

IINN Rankings

IINN Latest News

IINN Stock Data

38.05M
9.57M
9.47%
9.3%
1.39%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Raanana

About IINN

insense medical develops state of the art respiratory support technology as an alternative to mechanical ventilation by 2020 more than 600,000 patients in the u.s. will require mechanical ventilation. 5.7 million patients are admitted annually to icu's with 35% needing ventilation. cost of treatment is estimated at 64 bn$/y as mortality reaches 40%. imagine that instead of mechanical ventilation, or ecmo treatment, a small and safe apparatus is placed into a vein, replacing necessary lung functions without the devastating complications associated with mechanical ventilation. oxylink, an advanced nano vesicle technology. our revolutionary intravascular oxygenation apparatus, safely increases the level of oxygen & reduces the carbon dioxide in blood, enabling your physician to address the primary ventilatory condition.